Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
L179, bringing L1-79 autism research to NIH’s attention to seek 75 million for Phase 3 trials. all fees will be sent to researchers at Yamopharma